UK ministers secure 114m more Covid vaccines for next two years

Extra Pfizer/BioNTech and Moderna jabs for 2022 and 2023 ordered to ‘future proof’ vaccine programme

Ministers in the UK have secured new contracts to buy 114m more Covid-19 vaccines for the next two years.

The deals, for 2022 and 2023, were accelerated after the emergence of the Omicron coronavirus variant, officials said. Under the agreements, the UK will buy 54m more doses from Pfizer/BioNTech and 60m more doses from Moderna.

These purchases are in addition to the 35m extra Pfizer/BioNTech doses ordered in August for delivery in the second half of 2022, officials said. The UK is also still expecting 60m Novavax and 7.5m GSK/Sanofi doses in 2022.

Sajid Javid, the health secretary, said the new deals would “future proof” the UK’s vaccine programme and ensure protection for “even more people in the years ahead”.

There remains uncertainty about further health programmes. Some experts have warned that Covid-19 will have to be kept at bay by repeated vaccine campaigns, while others have said it is too early to tell whether annual vaccine boosters will be needed.

Officials at the Department of Health and Social Care said the new contracts included access to modified vaccines if needed to combat Omicron and future variants of concern.

The government said it had enough supplies of both Moderna and Pfizer/BioNTech doses for the current expansion of the booster programme.

Ministers said this week that all adults in the UK would be offered a booster shot before the end of January, amid growing concerns about the Omicron variant. Vaccination experts advising the government have expressed preference for the mRNA vaccines from Pfizer and Moderna.

Trial data suggest booster doses are generally well tolerated and provide a substantial increase in vaccine-induced immune responses, in particular, and that mRNA vaccines provide a strong booster effect.

Javid said: “These new deals will future proof the Great British vaccination effort, which has so far delivered more than 115 million first, second and booster jabs across the UK, and will ensure we can protect even more people in the years ahead.

“This is a national mission, and our best weapon to deal with this virus and its variants is to get jabs in arms. So when you are called forward, get the jab and get boosted.”

Contributor

Andrew Gregory Health editor

The GuardianTramp

Related Content

Article image
UK orders extra Covid vaccines for autumn 2022 booster campaign
Pfizer reportedly asked to supply 35m more doses, with final go-ahead for this year’s programme still awaited

Andrew Sparrow Political correspondent

11, Aug, 2021 @9:51 AM

Article image
UK orders 60m more doses of Pfizer Covid vaccine for booster jabs
Health secretary says greater supplies of vaccine will help safeguard progress in tackling coronavirus

Nicola Davis

28, Apr, 2021 @4:14 PM

Article image
What Covid vaccines does the UK have and which are in the works?
As Valneva recruits volunteers for final stage trials of its vaccine, here is the current state of play in Britain

Ian Sample Science editor

25, Apr, 2021 @11:01 PM

Article image
Number of UK Covid vaccinations falls by a third as vaccine supply dips
Factors at play include high uptake plus stockpiling for second doses, but Matt Hancock promises ‘bumper weeks in March’

Dan Sabbagh and Natalie Grover

23, Feb, 2021 @7:57 PM

Article image
Analysis: is it wise for England to mix and match Covid vaccines?
US experts warn against plan to give different second jab if supplies run low

Sarah Boseley Health editor

03, Jan, 2021 @5:39 PM

Article image
6 key questions about the Pfizer/BioNTech Covid-19 vaccine
There are grounds for optimism but also several unknowns around this coronavirus vaccine

Natalie Grover Science correspondent

10, Nov, 2020 @3:58 PM

Article image
Failure to share Covid vaccines ‘coming back to haunt us’, says Gordon Brown
Ex-PM says world was ‘forewarned’ of dangers of failing to vaccinate poorer countries amid rise of new variant

Nicola Davis and Rowena Mason

26, Nov, 2021 @4:01 PM

Article image
From Pfizer to Moderna: who's making billions from Covid-19 vaccines?
The companies in line for the biggest windfalls – and the shareholders who have already made fortunes

Julia Kollewe

06, Mar, 2021 @11:55 AM

Article image
Vaccine experts call for clarity on UK's 12-week Covid jab interval
British Society for Immunology calls for a robust programme monitoring the body’s immune response

Nicola Davis Science correspondent

24, Jan, 2021 @2:51 PM

Article image
Million Pfizer jabs face being dumped after Israel-UK swap deal fails
Israel says technical issues have scuppered deal to give UK Covid vaccines expiring on 30 July

Harriet Sherwood

02, Jul, 2021 @11:32 AM